作者: J. Yun , W. Zhang , D. Park , D. Yang , O. Press
DOI: 10.1200/JCO.2004.22.90140.3519
关键词: In patient 、 Internal medicine 、 Oncology 、 Oxaliplatin 、 Colorectal cancer 、 Chemotherapy 、 Medicine
摘要: 3519 Background: Genetic polymorphisms have been shown to predict clinical outcome 5-Fluorouracil/Oxaliplatin chemotherapy in patients with colorectal cancer. We retrospective stud...